Biotherapies Incorporated is a cancer research and development company dedicated to finding new cancer therapies and diagnostics to improve the quality of life and prognosis for cancer patients worldwide.
The company’s current product platform centers around the use of tissue specific growth inhibitory proteins to control and diagnose cancer. The company’s first product-concept centered on Mammastatin as a major medical breakthrough in the diagnosis and treatment of breast cancer. Recent research has identified other breast cancer inhibitors, and similar proteins in other, frequently cancerous, tissues. It is anticipated, therefore, that a full line of “natural” growth inhibitory, protein-based products will be developed to treat and diagnose the full range of human cancers.
The Company has now developed contract research, service offerings to complement its cancer products in late stage development.
We' ve built a long standing relationship based on trust